PepGen

PepGen DSCR

The Debt Service Coverage Ratio (DSCR) of PepGen (PEPG) as of Oct 16, 2026 is -25.61.

DSCR

-25.61

Last updated:

Debt Service Coverage Ratio (DSCR) of PepGen is 2025 -25.61 . Debt Service Coverage Ratio (DSCR) of PepGen was 2024 - . It decreases by % lower compared to the previous year.

The PepGen DSCR history

The PepGen DSCR history
YEARDSCRYoY
-25.61—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PepGen Stock analysis

What does PepGen do? PepGen Inc., based in Cambridge, Massachusetts, is a biotechnology company focused on developing oligonucleotide therapies for neuromuscular and neurologic diseases. The company utilizes its enhanced delivery oligonucleotide (EDO) platform, which employs cell-penetrating peptides to enhance therapeutic delivery. Its lead candidates, PGN-EDO51 for Duchenne muscular dystrophy and PGN-EDODM1 for myotonic dystrophy type 1, are part of a pipeline targeting degenerative conditions. Listed on 6 May 2022, PepGen operates with a team of 56 employees. PepGen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about PepGen stock

Debt Service Coverage Ratio (DSCR) of PepGen is -25.61 in 2025.

On Eulerpool you can find the complete historical development of Debt Service Coverage Ratio (DSCR) PepGen since 2006 – with annual values, charts, and detailed analysis.

The DSCR measures a company's ability to service its debt obligations from operating income. A ratio above 1.0 indicates sufficient income to cover debt payments.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Debt Service Coverage Ratio (DSCR)'s PepGen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — PepGen

All Key Metrics — PepGen